The Covid-19 pandemic has affected us all – personally, professionally and financially.
But with adversity comes opportunity, for those able to successfully pivot. Because you have been involved in clinical research, you may be insulated from economic d…https://t.co/bCq6pau9Do
An interview I did with Alan Rapoport at the 2019 HCNE meeting in Stowe VT. Here we discuss CGRP therapy for migraines - the controversies of knowns and unknowns.
https://t.co/6frrFgxJMb
For migraine sufferers, the good new is, at least for now, the new CGRP injectables are - pretty much - free, says Kate Mullin MD of the New England Institute for Neurology and Headache. Check out the story:
#migraine#checks#injections https://t.co/W1GTjXUncH
My latest column of Headache Horizons in the Sept. issue of Practical Neurology. It's a philosophical riff of what we - and our patients - mean when we talk about headache. https://t.co/Su5D42J7Yd
Hot off the presses - the first article in my new monthly column called Headache Horizons, in the June edition of Practical Neurology. Full article here: https://t.co/ueeGkP8g4O